[Progress on diagnosis of Wegener's granulomatosis].
Kondo
H
H
D000328:Adult; D000900:Anti-Bacterial Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies / Q000032:analysis; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D008297:Male; D053146:Myeloblastin; D011239:Prednisolone / Q000008:administration & dosage; D012697:Serine Endopeptidases / Q000276:immunology; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D001323:Autoantibodies; D003520:Cyclophosphamide; D011239:Prednisolone; D014295:Trimethoprim; D012697:Serine Endopeptidases; D053146:Myeloblastin; D013420:Sulfamethoxazole